Swiss Parenterals Limited — Fosfomycin Exporter Profile
Indian Pharmaceutical Exporter · #2 for Fosfomycin · $1.4M export value · DGFT Verified
Swiss Parenterals Limited is the #2 Indian exporter of Fosfomycin with $1.4M in export value and 27 verified shipments. Swiss Parenterals Limited holds a 10.5% market share in Fosfomycin exports across 2 countries. The company exports 18 pharmaceutical products worth $15.9M across 9 therapeutic categories.
Swiss Parenterals Limited — Fosfomycin Export Profile: Buyers & Destinations
Where Does Swiss Parenterals Limited Export Fosfomycin?
Swiss Parenterals Limited exports Fosfomycin to 2 countries. The largest destination is GERMANY accounting for 73.8% of Swiss Parenterals Limited's Fosfomycin shipments. These destinations reflect Swiss Parenterals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fosfomycin from Swiss Parenterals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | GERMANY | $849.4K | 21 |
| TO THE ORDER | GERMANY | $150.0K | 3 |
| TO THE ORDER OF, | GERMANY | $33.0K | 1 |
| TO THE ORDER OF | TUNISIA | $19.5K | 1 |
| TO THE ORDER OF | TUNISIA | $16.5K | 1 |
Swiss Parenterals Limited supplies Fosfomycin to 5 buyers globally. The largest buyer is TO THE ORDER OF (GERMANY), followed by TO THE ORDER (GERMANY) and TO THE ORDER OF, (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fosfomycin Export Value and How Much Does Swiss Parenterals Limited Contribute?
India exported $8.2M worth of Fosfomycin through 492 shipments from 73 suppliers to 46 countries, serving 88 buyers globally. Swiss Parenterals Limited contributes $1.4M to this total, accounting for 10.5% of India's Fosfomycin exports. Swiss Parenterals Limited ships Fosfomycin to 2 countries through 5 buyers.
What Is the Average Shipment Value for Swiss Parenterals Limited's Fosfomycin Exports?
Swiss Parenterals Limited's average Fosfomycin shipment value is $50.0K per consignment, based on 27 shipments totaling $1.4M. The largest destination is GERMANY (73.8% of Swiss Parenterals Limited's Fosfomycin exports).
How Does Swiss Parenterals Limited Compare to Other Indian Fosfomycin Exporters?
Swiss Parenterals Limited ranks #2 among 73 Indian Fosfomycin exporters with a 10.5% market share. The top 3 exporters are CIPLA LIMITED ($6.0M), SWISS PARENTERALS LIMITED ($1.4M), SRS PHARMACEUTICALS PRIVATE LIMITED ($285.3K). Swiss Parenterals Limited processed 27 shipments to 2 destination countries.
What Fosfomycin Formulations Does Swiss Parenterals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FOSFOMYCIN EBERTH 10X4,0 G (mfg dt: dec- | $200.0K | 4 |
| PHARMACEUTICAL GOODS / HARMLESS MEDICINES FOR HUMAN USE - FOSFOMYCIN EBERTH 10X4,0 G. FOSFOMYCIN SODIUM FOR INJECTION 4. | $100.0K | 2 |
| PHARMACEUTICAL GOODS/HARMLESS MEDICINESFOR HUMAN USE-FOSFOMYCIN SODIUM POWDER FOR SOLUTION FOR INFUSION 4GM(3,000 PACK | $100.0K | 2 |
| PHARMACEUTICAL GOODS/HARMLESS MEDICINESFOR HUMAN USE-FOSFOMYCIN SODIUM POWDER FOR SOLUTION FOR INFUSION 4GM(3000 PACKS) | $100.0K | 2 |
| PHARMACEUTICAL GOODS / HARMLESS MEDICINES FOR HUMAN USE - FOSFOMYCIN EBERTH 10X4,0 G. FOSFOMYCIN SODIUM FOR INJECTION 4.NOS | $88.0K | 2 |
| FOSFOMYCIN EBERTH 10X4,0 G FOSFOMYCIN SO | $83.0K | 2 |
| FOSFOMYCIN EBERTH 10X2,0 G (Mfg dt: Nov- | $59.4K | 2 |
| PHARMACEUTICAL GO ARTICLE / ODS / PRODUCT / ITEM / HARMLESS MEDICINES FOR HUMAN USE - FOSFOMYCIN EBERTH 10X4,0 G DETAILS AS PER INVOICE 1778 PAC | $50.0K | 1 |
| PHARMACEUTICAL GO ARTICLE / ODS / PRODUCT / ITEM / HARMLESS MEDICINES FOR HUMAN USE - FOSFOMYCIN EBERTH 10X40 G. FOSFOMYCIN SODIUM FOR INJECTION 4. | $50.0K | 1 |
| PHARMACEUTICAL GOODS / HARMLESS MEDICINES FOR HUMAN USE - FOSFOMYCIN EBERTH 10X2,0 G. FOSFOMYCIN SODIUM FOR INJECTION 2. | $50.0K | 1 |
Swiss Parenterals Limited exports 20 distinct Fosfomycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FOSFOMYCIN EBERTH 10X4,0 G (mfg dt: dec- with 4 shipments worth $200.0K.
Regulatory Requirements: Exporting Fosfomycin to Key Markets
What Swiss Parenterals Limited must comply with to export Fosfomycin to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Swiss Parenterals Limited Compare to Nearest Fosfomycin Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA LIMITED | $6.0M | 120 | 2 | $50.0K |
| 2 | SWISS PARENTERALS LIMITED ★ | $1.4M | 27 | 2 | $50.0K |
| 3 | SRS PHARMACEUTICALS PRIVATE LIMITED | $285.3K | 9 | 2 | $31.7K |
| 5 | AVANTIKA MEDEX PRIVATE LIMITED | $172.6K | 6 | 1 | $28.8K |
Swiss Parenterals Limited ranks #2 among 73 Indian Fosfomycin exporters. Average shipment value of $50.0K compared to the market average of $112.6K. The closest competitors by value are CIPLA LIMITED and SRS PHARMACEUTICALS PRIVATE LIMITED.
Which Indian Ports Ship Fosfomycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 99 | 20.1% |
| DELHI AIR CARGO ACC (INDEL4) | 86 | 17.5% |
| SAHAR AIR | 77 | 15.7% |
| DELHI AIR | 50 | 10.2% |
| Bombay Air | 24 | 4.9% |
| JNPT/ NHAVA SHEVA SEA | 24 | 4.9% |
| AHEMDABAD AIR ACC (INAMD4) | 16 | 3.3% |
| NHAVA SHEVA SEA (INNSA1) | 16 | 3.3% |
What Other Advanced Antibiotics Products Does Swiss Parenterals Limited Export?
Swiss Parenterals Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Swiss Parenterals Limited's Fosfomycin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Swiss Parenterals. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended delivery times. Such maritime challenges can significantly impact the timely distribution of pharmaceuticals, especially to Middle Eastern markets. (pharmaceuticalcommerce.com)
Conversely, escalating US-China trade tensions have prompted the United States to diversify its import sources, potentially benefiting Indian exporters. However, recent US tariff policies, including a 25% tariff on Indian imports due to geopolitical alignments, pose a substantial challenge, potentially affecting nearly 55% of India's exports to the US. (apnews.com)
In the European Union, stringent regulatory frameworks like the Falsified Medicines Directive necessitate compliance with rigorous safety and quality standards. For companies like Swiss Parenterals, adhering to these regulations is crucial to maintain and expand their presence in EU markets.
Swiss Parenterals Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened scrutiny regarding quality and compliance. Indian exporters, including Swiss Parenterals, must navigate complex regulatory environments, ensuring adherence to FDA, WHO, and EU GMP standards. The US FDA's increased inspections of Indian facilities underscore the importance of maintaining high-quality manufacturing practices to avoid potential export bans or recalls. (fact.net.in)
Swiss Parenterals' integration into Eris Lifesciences is expected to bolster its compliance infrastructure, leveraging Eris's established quality management systems to meet international regulatory requirements effectively.
About Swiss Parenterals Limited
Swiss Parenterals Limited exports 18 products worth $15.9M. Beyond Fosfomycin, top products include Ceftriaxone, Meropenem, Prednisolone, Methylprednisolone, Hydrocortisone. View the complete Swiss Parenterals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fosfomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fosfomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Swiss Parenterals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 29 individual customs records matching Swiss Parenterals Limited exporting Fosfomycin, covering 20 formulations to 2 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 46+ countries, 88+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fosfomycin Export Data from Swiss Parenterals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Swiss Parenterals Limited's Fosfomycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Swiss Parenterals Limited
Full Company Profile →
18 products · $15.9M total trade · 9 categories
Fosfomycin Stats
Company Overview
Top Products by Swiss Parenterals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Swiss Parenterals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fosfomycin. For current shipment-level data, contact TransData Nexus.